A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
about
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathwaysAn educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).Therapeutic potential of peroxynitrite decomposition catalysts: a patent review.Catalytic antioxidant therapy by metallodrugs: lessons from metallocorroles.MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.Nonclinical Safety and Toxicokinetics of MnTnBuOE-2-PyP5+ (BMX-001).Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues.Radiation-mediated tumor growth inhibition is significantly enhanced with redox-active compounds that cycle with ascorbate.Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues.
P2860
Q28385000-13159661-C111-46C1-B7DE-4C8A337FF10FQ35349280-78333E74-614E-429B-879C-85A37F8861BFQ35496324-CF7966DC-D5B6-4A98-82BE-17D49E887603Q35639007-1A5790B7-4BBB-4E9A-9AEB-57B84E35587CQ37629336-5E50A6B7-DF39-4A34-B9B6-63829D7261F6Q38313367-77258415-3403-41A1-9D8A-5624D9F35F25Q38348969-776A4B31-C80C-4A40-AB4A-1B0EAD9215FAQ38948245-A178FEFA-577A-4608-B4CA-9565F04E6D05Q39835723-EC6EF673-7A2F-4B96-99C1-7A38A18640CCQ46268603-02813826-6D29-434B-8489-D53518CF5301Q47112999-5C789D58-B553-4C21-8B8F-53BA49FAC158Q49484285-E62FA538-DFBD-4408-ACD6-B03FCE7FF554Q50927204-8304BC6B-1EC6-4111-A418-4432C7672DD8
P2860
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@en
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@nl
type
label
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@en
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@nl
prefLabel
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@en
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@nl
P2093
P2860
P356
P1476
A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
@en
P2093
Charles B Spainhour
Dexter W Sullivan
James D Crapo
Shayne C Gad
P2860
P304
P356
10.1177/1091581813490203
P577
2013-05-23T00:00:00Z